查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587467

小分子 API 连续製造市场规模、份额、趋势分析报告：按设备、按单元操作、按类型、按最终用途、按地区、细分市场预测，2024-2030 年

Continuous Manufacturing For Small Molecule APIs Market Size, Share & Trends Analysis Report By Equipment (Reactors, Crystallizers, Filtration Systems), By Unit Operation, By Type, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

小分子 API 连续製造市场成长与趋势：

Grand View Research, Inc.的研究报告显示，到2030年，全球小分子API连续製造市场规模预计将达到67,152万美元，2024年至2030年复合年增长率为10.42%。

这种强劲的扩张得益于反映当前行业趋势、技术进步和监管环境变化的几个关键驱动因素。连续製造流程与传统批量加工相比具有显着优势，包括提高效率、降低製造成本和提高产品品质。美国食品药物管理局(FDA) 认识到其在简化药品生产流程和提高整体药品品质方面的潜力，积极推广连续生产技术。例如，FDA 的 21 世纪药品品质计画已将连续生产确定为重点关注领域，并鼓励公司采用这些创新方法来更好地控制生产变数。

最近的技术进步进一步推动了连续製造市场的发展。製程分析技术 (PAT) 的创新可即时监控生产流程，确保品质稳定并符合监管标准。例如，2024 年 7 月，GEA 宣布了一项新的连续加工技术，旨在提高药品製造的灵活性和效率。在 ACHEMA 2024 上，GEA 展示了与 Hobione 的合作，重点介绍了 ConsiGma CDC Flex 系统。该系统支援各种吞吐量的连续和批量流程，从而提高生产品质和永续性。这些技术不仅提高了效率，还大大缩短了新药的上市时间，使其成为竞争日益激烈的製药行业的重要组成部分。

政府的倡议和支持在连续製造市场的成长中也发挥着重要作用。各国已经认识到需要实现药品製造现代化，以增强竞争力并改善公共卫生成果。例如，美国政府推出了旨在加速采用连续製造技术的计划，提供资金和资源来支持产业内的创新。同样，欧洲药品管理局 (EMA) 推广指导方针，以加速欧洲製药业采用这些技术，并鼓励使用连续流程。

小分子 API 连续製造市场报告亮点

  • 从设备来看，反应器将在 2023 年以 35.2% 的显着份额主导市场，预计在预测期内将以 11.0% 的复合年增长率增长最快。
  • 从设备来看，到 2023 年，合成设备将占据最大的销售份额，达到 39.1%，并且在技术进步、效率提升和向永续实践转变的推动下，预计未来几年将继续扩大。
  • 按类型划分，非专利原料药占市场主导地位，2023 年收益占有率高达 10.8%。
  • 按最终用途划分，CMO/CDMO 占据市场主导地位，到 2023 年将占据 70.2% 的巨大收益占有率。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章小分子 API 连续製造市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 小分子API连续製造市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章小分子原料药连续生产市场：设备估算及趋势分析

  • 小分子 API 连续製造的全球市场：设备仪表板
  • 全球小分子原料药连续生产市场：设备波动分析
  • 全球小分子 API 连续生产市场：按设备分類的收益
  • 核子反应炉
  • 结晶设备
  • 过滤系统
  • 搅拌机
  • 热交换器
  • 其他（烘干机等）

第五章 小分子原料药连续生产市场：装置运作预测及趋势分析

  • 小分子 API 连续製造的全球市场：单元操作仪表板
  • 全球小分子原料药连续生产市场：单元操作变化分析
  • 按单位营运收益
  • 合成
  • 分离精製
  • 烘干

第六章 小分子原料药连续生产市场：类型估计与趋势分析

  • 小分子 API 连续製造的全球市场：类型仪表板
  • 小分子 API 连续生产的全球市场：类型变异分析
  • 按类型分類的收益
  • 一般API
  • 创新的API

第七章 小分子 API 连续製造市场：最终用途估计与趋势分析

  • 小分子 API 连续製造的全球市场：最终用途仪表板
  • 小分子 API 连续製造的全球市场：最终用途变化分析
  • 按最终用途分類的收益
  • CMO/CDMO
  • 製药公司
  • 学术研究所

第 8 章小分子 API 连续製造市场：按设备、单元操作、类型和最终用途进行的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • Key company market share analysis, 2023
    • Pfizer Inc
    • GSK plc.（GlaxoSmithKline）
    • Vertex Pharmaceuticals Incorporated
    • Janssen（a subsidiary of Johnson &Johnson）
    • Abbvie Inc.
    • Sterling Pharma Solutions
    • Evonik Industries AG
    • Cambrex Corporation
    • Patheon
    • Hovione
    • Lonza
    • Phlow
    • Asymchem
    • GEA Group AG
    • Thermo Fisher Scientific
    • Corning Incorporated
    • Coperion GmbH
    • Continuus Pharmaceuticals
    • Chemtrix
    • Vapourtec Ltd
    • Ehrfeld Mikrotechnik GmbH
    • NiTech Solutions Ltd
Product Code: GVR-4-68040-472-6

Continuous Manufacturing For Small Molecule APIs Market Growth & Trends:

The global continuous manufacturing for small molecule APIs market size is anticipated to reach USD 671.52 million by 2030, growing at a CAGR of 10.42% from 2024 to 2030, according to a report by Grand View Research, Inc. This robust expansion can be attributed to several key drivers that reflect current industry trends, advancements in technology, and changing regulatory landscapes. Continuous manufacturing processes offer significant advantages over traditional batch processing, including increased efficiency, reduced production costs, and improved product quality. The United States Food and Drug Administration (FDA) has actively promoted continuous manufacturing technologies, recognizing their potential to streamline the drug production process and enhance the overall quality of pharmaceutical products. For instance, the FDA's "Pharmaceutical Quality for the 21st Century" initiative highlights continuous manufacturing as a key focus area, encouraging companies to adopt these innovative approaches to ensure better control over production variables.

Recent technological advancements further propel the continuous manufacturing market. Innovations in process analytical technology (PAT) enable real-time monitoring of production processes, ensuring consistent quality and compliance with regulatory standards. For instance, in July 2024, GEA introduced new continuous processing technologies designed to enhance flexibility and efficiency in pharmaceutical manufacturing. At ACHEMA 2024, GEA showcased its collaboration with Hovione, emphasizing the ConsiGma CDC flex system. This system supports both continuous and batch processes with varied throughput, improving production quality and sustainability. Their partnership aims to simplify operations and make continuous manufacturing more accessible across the industry.These technologies not only increase efficiency but also significantly shorten time-to-market for new drugs, an essential factor in an increasingly competitive pharmaceutical industry.

Government initiatives and support also play a crucial role in the growth of the continuous manufacturing market. Various countries are recognizing the need for modernization in pharmaceutical manufacturing to enhance competitiveness and improve public health outcomes. For example, the U.S. government has introduced programs aimed at facilitating the adoption of continuous manufacturing technologies, providing funding and resources to support innovation within the industry. Similarly, the European Medicines Agency (EMA) has been encouraging the use of continuous processes, promoting guidelines that facilitate the implementation of these technologies within Europe's pharmaceutical sector.

Continuous Manufacturing For Small Molecule APIs Market Report Highlights:

  • Based on equipment, reactors dominated the market with a substantial share of 35.2% in 2023 and are expected to grow at the fastest CAGR of 11.0% during the forecast period
  • Based on unit operation, the synthesis segment held the largest revenue share of 39.1% in 2023 driven by technological advancements, efficiency gains, and a shift toward sustainable practices, positioning it for continued expansion in the coming years
  • Based on type, generic APIs dominated the market, capturing a substantial revenue share of 10.8% in 2023
  • Based on end use, CMO/CDMOs dominated the market, capturing a substantial revenue share of 70.2% in 2023

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Equipment
    • 1.2.2. Unit Operation
    • 1.2.3. Type
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Equipment Outlook
    • 2.2.2. Unit Operation
    • 2.2.3. Type
    • 2.2.4. End Use
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Continuous Manufacturing for Small Molecule APIs Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rapid growth in the global pharmaceutical industry
      • 3.2.1.2. Growing role of flow chemistry in API manufacturing
      • 3.2.1.3. Growing adoption and improved efficiency & productivity
      • 3.2.1.4. Emergence as a green, sustainable and profitable process technology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High R&D investment and capital cost
      • 3.2.2.2. Regulatory compliance and process validation
  • 3.3. Continuous Manufacturing for Small Molecule APIs Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Continuous Manufacturing for Small Molecule APIs Market: Equipment Estimates & Trend Analysis

  • 4.1. Global Continuous Manufacturing for Small Molecule APIs Market: Equipment Dashboard
  • 4.2. Global Continuous Manufacturing for Small Molecule APIs Market: Equipment Movement Analysis
  • 4.3. Global Continuous Manufacturing for Small Molecule APIs Market by Equipment, Revenue
  • 4.4. Reactors
    • 4.4.1. Reactors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Crystallizers
    • 4.5.1. Crystallizers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Filtration Systems
    • 4.6.1. Filtration Systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Mixers
    • 4.7.1. Mixers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Heat Exchangers
    • 4.8.1. Heat Exchangers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Others (Dryers, etc.)
    • 4.9.1. Others (Dryers, etc.) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Estimates & Trend Analysis

  • 5.1. Global Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Dashboard
  • 5.2. Global Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Movement Analysis
  • 5.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By Unit Operation, Revenue (USD Million)
  • 5.4. Synthesis
    • 5.4.1. Synthesis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Separation & Purification
    • 5.5.1. Separation & Purification market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Drying
    • 5.6.1. Drying market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Continuous Manufacturing for Small Molecule APIs Market: Type Estimates & Trend Analysis

  • 6.1. Global Continuous Manufacturing for Small Molecule APIs Market: Type Dashboard
  • 6.2. Global Continuous Manufacturing for Small Molecule APIs Market: Type Movement Analysis
  • 6.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By Type, Revenue (USD Million)
  • 6.4. Generic APIs
    • 6.4.1. Generic APIs market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Innovative APIs
    • 6.5.1. Innovative APIs market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Continuous Manufacturing for Small Molecule APIs Market: End Use Estimates & Trend Analysis

  • 7.1. Global Continuous Manufacturing for Small Molecule APIs Market: End Use Dashboard
  • 7.2. Global Continuous Manufacturing for Small Molecule APIs Market: End Use Movement Analysis
  • 7.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 7.4. CMOs/CDMOs
    • 7.4.1. CMOs/CDMOs market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Pharmaceutical Companies
    • 7.5.1. Pharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Continuous Manufacturing for Small Molecule APIs Market: Regional Estimates & Trend Analysis by Equipment, Unit Operation, Type and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Vendor Landscape
    • 9.2.1. List of key distributors and channel partners
    • 9.2.2. Key company market share analysis, 2023
    • 9.2.3. Pfizer Inc
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Equipment benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. GSK plc. (GlaxoSmithKline)
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Equipment benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Vertex Pharmaceuticals Incorporated
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Equipment benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Janssen (a subsidiary of Johnson & Johnson)
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Equipment benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Abbvie Inc.
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Equipment benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Sterling Pharma Solutions
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Equipment benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Evonik Industries AG
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Equipment benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Cambrex Corporation
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Equipment benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Patheon
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Equipment benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. Hovione
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Equipment benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. Lonza
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Equipment benchmarking
      • 9.2.13.4. Strategic initiatives
    • 9.2.14. Phlow
      • 9.2.14.1. Company overview
      • 9.2.14.2. Financial performance
      • 9.2.14.3. Equipment benchmarking
      • 9.2.14.4. Strategic initiatives
    • 9.2.15. Asymchem
      • 9.2.15.1. Company overview
      • 9.2.15.2. Financial performance
      • 9.2.15.3. Equipment benchmarking
      • 9.2.15.4. Strategic initiatives
    • 9.2.16. GEA Group AG
      • 9.2.16.1. Company overview
      • 9.2.16.2. Financial performance
      • 9.2.16.3. Equipment benchmarking
      • 9.2.16.4. Strategic initiatives
    • 9.2.17. Thermo Fisher Scientific
      • 9.2.17.1. Company overview
      • 9.2.17.2. Financial performance
      • 9.2.17.3. Equipment benchmarking
      • 9.2.17.4. Strategic initiatives
    • 9.2.18. Corning Incorporated
      • 9.2.18.1. Company overview
      • 9.2.18.2. Financial performance
      • 9.2.18.3. Equipment benchmarking
      • 9.2.18.4. Strategic initiatives
    • 9.2.19. Coperion GmbH
      • 9.2.19.1. Company overview
      • 9.2.19.2. Financial performance
      • 9.2.19.3. Equipment benchmarking
      • 9.2.19.4. Strategic initiatives
    • 9.2.20. Continuus Pharmaceuticals
      • 9.2.20.1. Company overview
      • 9.2.20.2. Financial performance
      • 9.2.20.3. Equipment benchmarking
      • 9.2.20.4. Strategic initiatives
    • 9.2.21. Chemtrix
      • 9.2.21.1. Company overview
      • 9.2.21.2. Financial performance
      • 9.2.21.3. Equipment benchmarking
      • 9.2.21.4. Strategic initiatives
    • 9.2.22. Vapourtec Ltd
      • 9.2.22.1. Company overview
      • 9.2.22.2. Financial performance
      • 9.2.22.3. Equipment benchmarking
      • 9.2.22.4. Strategic initiatives
    • 9.2.23. Ehrfeld Mikrotechnik GmbH
      • 9.2.23.1. Company overview
      • 9.2.23.2. Financial performance
      • 9.2.23.3. Equipment benchmarking
      • 9.2.23.4. Strategic initiatives
    • 9.2.24. NiTech Solutions Ltd
      • 9.2.24.1. Company overview
      • 9.2.24.2. Financial performance
      • 9.2.24.3. Equipment benchmarking
      • 9.2.24.4. Strategic initiatives

List of Tables

  • Table 1 List Of Abbreviation
  • Table 2 North America Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 4 North America Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 5 North America Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 North America Continuous Manufacturing for Small Molecule APIs Market, End Use, 2018 - 2030 (USD Million)
  • Table 7 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 8 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 9 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11 Canada Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 12 Canada Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 13 Canada Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 16 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 17 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Mexico Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
  • Table 20 Europe Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 21 Europe Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 22 Europe Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24 Germany Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 25 Germany Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 26 Germany Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 UK Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 29 UK Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 30 UK Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 UK Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 France Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 33 France Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 34 France Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 France Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36 Italy Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 37 Italy Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 38 Italy Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Spain Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 41 Spain Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 42 Spain Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 45 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 46 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 49 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 50 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Norway Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 53 Norway Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 54 Norway Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 China Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 62 China Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 63 China Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 China Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Japan Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 66 Japan Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 67 Japan Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 Japan Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69 India Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 70 India Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 71 India Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 India Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 74 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 75 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 77 Australia Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 78 Australia Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 79 Australia Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 Australia Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 82 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 83 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
  • Table 86 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 87 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 88 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 90 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 91 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 92 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 95 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 96 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 97 Argentina Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 98 MEA Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
  • Table 99 MEA Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 100 MEA Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 101 MEA Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 102 MEA Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 103 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 104 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 105 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 South Africa Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 111 UAE Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 112 UAE Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 113 UAE Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 114 UAE Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Continuous Manufacturing for Small Molecule APIs Market: Market Outlook
  • Fig. 14 Colorectal Surgery Competitive Insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Continuous Manufacturing for Small Molecule APIs Market Driver Impact
  • Fig. 18 Continuous Manufacturing for Small Molecule APIs Market Restraint Impact
  • Fig. 19 Continuous Manufacturing for Small Molecule APIs Market Strategic Initiatives Analysis
  • Fig. 20 Continuous Manufacturing for Small Molecule APIs Market: Equipment Movement Analysis
  • Fig. 21 Continuous Manufacturing for Small Molecule APIs Market: Equipment Outlook And Key Takeaways
  • Fig. 22 Reactors market estimates and forecast, 2018 - 2030
  • Fig. 23 Crystallizers market estimates and forecast, 2018 - 2030
  • Fig. 24 Filtration Systems market estimates and forecast, 2018 - 2030
  • Fig. 25 Mixers market estimates and forecast, 2018 - 2030
  • Fig. 26 Heat Exchangers market estimates and forecast, 2018 - 2030
  • Fig. 27 Others (Dryers, etc.) market estimates and forecast, 2018 - 2030
  • Fig. 28 Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Movement Analysis
  • Fig. 29 Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Outlook And Key Takeaways
  • Fig. 30 Synthesis market estimates and forecast, 2018 - 2030
  • Fig. 31 Separation & Purification Separation & Purification market estimates and forecast, 2018 - 2030
  • Fig. 32 Continuous Manufacturing for Small Molecule APIs Market: Type Movement Analysis
  • Fig. 33 Continuous Manufacturing for Small Molecule APIs Market: Type Outlook And Key Takeaways
  • Fig. 34 Generic APIs market estimates and forecast, 2018 - 2030
  • Fig. 35 Innovative APIs market estimates and forecast, 2018 - 2030
  • Fig. 36 Continuous Manufacturing for Small Molecule APIs Market: End Use Movement Analysis
  • Fig. 37 Continuous Manufacturing for Small Molecule APIs Market: End Use Outlook And Key Takeaways
  • Fig. 38 CMOs/CDMOs market estimates and forecast, 2018 - 2030
  • Fig. 39 Pharmaceutical Companies market estimates and forecast, 2018 - 2030
  • Fig. 40 Academic & Research Institutes market estimates and forecast, 2018 - 2030
  • Fig. 41 Global Continuous Manufacturing for Small Molecule APIs Market: Regional Movement Analysis
  • Fig. 42 Global Continuous Manufacturing for Small Molecule APIs Market: Regional Outlook And Key Takeaways
  • Fig. 43 Global Continuous Manufacturing for Small Molecule APIs Market share and leading players
  • Fig. 44 North America, by country
  • Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. key country dynamics
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada key country dynamics
  • Fig. 49 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico key country dynamics
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 UK key country dynamics
  • Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Germany key country dynamics
  • Fig. 56 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 France key country dynamics
  • Fig. 58 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Italy key country dynamics
  • Fig. 60 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Spain key country dynamics
  • Fig. 62 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Denmark key country dynamics
  • Fig. 64 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Sweden key country dynamics
  • Fig. 66 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Norway key country dynamics
  • Fig. 68 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 China key country dynamics
  • Fig. 71 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Japan key country dynamics
  • Fig. 73 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 India key country dynamics
  • Fig. 75 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Thailand key country dynamics
  • Fig. 77 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 South Korea key country dynamics
  • Fig. 79 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Australia key country dynamics
  • Fig. 81 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil key country dynamics
  • Fig. 84 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina key country dynamics
  • Fig. 86 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa key country dynamics
  • Fig. 89 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia key country dynamics
  • Fig. 91 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 UAE key country dynamics
  • Fig. 93 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Kuwait key country dynamics
  • Fig. 95 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Market share of key market players- Continuous Manufacturing for Small Molecule APIs Market